1. Home
  2. AFMD vs APYX Comparison

AFMD vs APYX Comparison

Compare AFMD & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFMD
  • APYX
  • Stock Information
  • Founded
  • AFMD 2000
  • APYX 1982
  • Country
  • AFMD Germany
  • APYX United States
  • Employees
  • AFMD N/A
  • APYX N/A
  • Industry
  • AFMD Biotechnology: Pharmaceutical Preparations
  • APYX Medical/Dental Instruments
  • Sector
  • AFMD Health Care
  • APYX Health Care
  • Exchange
  • AFMD Nasdaq
  • APYX Nasdaq
  • Market Cap
  • AFMD 45.6M
  • APYX 42.3M
  • IPO Year
  • AFMD 2014
  • APYX 1987
  • Fundamental
  • Price
  • AFMD $1.27
  • APYX $1.59
  • Analyst Decision
  • AFMD Strong Buy
  • APYX Hold
  • Analyst Count
  • AFMD 5
  • APYX 2
  • Target Price
  • AFMD $13.50
  • APYX N/A
  • AVG Volume (30 Days)
  • AFMD 498.2K
  • APYX 68.5K
  • Earning Date
  • AFMD 11-14-2024
  • APYX 11-08-2024
  • Dividend Yield
  • AFMD N/A
  • APYX N/A
  • EPS Growth
  • AFMD N/A
  • APYX N/A
  • EPS
  • AFMD N/A
  • APYX N/A
  • Revenue
  • AFMD $6,287,085.00
  • APYX $48,542,000.00
  • Revenue This Year
  • AFMD N/A
  • APYX N/A
  • Revenue Next Year
  • AFMD $28.44
  • APYX $2.78
  • P/E Ratio
  • AFMD N/A
  • APYX N/A
  • Revenue Growth
  • AFMD N/A
  • APYX N/A
  • 52 Week Low
  • AFMD $1.40
  • APYX $0.97
  • 52 Week High
  • AFMD $8.95
  • APYX $2.80
  • Technical
  • Relative Strength Index (RSI)
  • AFMD 16.00
  • APYX 54.50
  • Support Level
  • AFMD $1.40
  • APYX $1.52
  • Resistance Level
  • AFMD $2.21
  • APYX $1.86
  • Average True Range (ATR)
  • AFMD 0.24
  • APYX 0.22
  • MACD
  • AFMD -0.08
  • APYX -0.01
  • Stochastic Oscillator
  • AFMD 3.33
  • APYX 42.06

About AFMD Affimed N.V.

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. It is active in the discovery, pre-clinical and clinical development of antibodies based on its core technology. The Company generates revenues from the provision of research and development services to third parties based on both Group and third party owned intellectual property. Geographically, it derives a majority of revenue from the United States and also has a presence in and Germany.

About APYX Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.

Share on Social Networks: